Alpha Cognition Inc. Common Stock ACOG
8.62 USD -0.11 (-1.26%)
At closeNov 11, 2026, 4:00 PM EST
8.66 +0.04 +0.46%
After hours · Nov 11, 4:00 PM ET
8.60 Day range 9.00
4.50 52-week range 10.14
- YTD
- +32.62%
- 1 year
- +40.85%
News
seekingalpha.com Alpha Cognition Inc. (ACOG) Q3 2026 Earnings Call Transcript Alpha Cognition Inc. (ACOG) Q3 2026 Earnings Call Transcript
zacks.com Alpha Cognition Inc. (ACOG) Reports Q3 Loss, Beats Revenue Estimates Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.3 per share a year ago.
marketbeat.com What Alpha Cognition (ACOG) Said on Its Q3 Earnings Call Alpha Cognition NASDAQ: ACOG reported third-quarter 2026 net product revenue of approximately $7.8 million, up 30% from the preceding quarter, as prescriptions and prescriber adoption increased for…
benzinga.com Alpha Cognition Q3 2026 Earnings Call Transcript Alpha Cognition (NASDAQ:ACOG) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
benzinga.com Alpha Cognition Q3 EPS $(0.35) Misses $(0.34) Estimate, Sales $7.777M Beat $7.040M Estimate Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.34) by 6.06 percent. This is a 16.67 percent decrease over losses of…
businesswire.com Alpha Cognition Inc. Reports Third Quarter 2026 Financial Results and Provides Operational Update VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing and…
businesswire.com Alpha Cognition Strengthens Its Board of Directors with Appointment of Caren Deardorf VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company developing and commercializing novel…
businesswire.com Alpha Cognition to Participate in Upcoming Investor Events VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company developing and commercializing…